The American pharmaceutical company, Aprecia Pharmaceuticals, recently announced that they will soon produce a drug that is printed with a 3-dimensional printer. The manufacturer claims that the drug produced by this method then first used in the world.
The drug named Spritam would later on be produced through the process of plated through printing with media three-dimensional printer. Manufacturers based in Ohio explains that every single drug that is packaged with 3-dimensional printing technology is going to pack a dose of 1,000 milligrams that can be used to reduce the effects of seizures due to epilepsy.
Aprecia Pharmaceuticals alone reportedly will soon produce and distribute the drug in bulk in the first quarter of 2016 after first obtaining permission from the Food and Drug Administration (FDA) or the National Agency of Drug and Food America. Going forward, Aprecia Pharmaceuticals wish they could produce more types of drugs, especially drugs for neurological problems using this method.